Article Figures & Data
Tables
Clinical Predictor All Neurocomplications Permanent Neurocomplications Neuromortality Age 0.4014 0.7392 0.2549 Sex 0.0846 0.0825 0.0283 Race: White 1.0000 1.0000 1.0000 Black 1.0000 0.6548 1.0000 Failed antiplatelet 0.4499 1.0000 1.0000 Failed coumadin ± heparin 0.1312 0.0685 0.1417 Comorbidity history: Cardiac 0.3172 1.0000 0.5142 Hypertension 0.7110 0.6927 0.4130 Diabetes 0.0378 0.0604 0.5277 Smoking 0.5470 0.1866 1.0000 Lipids 0.8759 0.4770 0.5142 CRF 1.0000 1.0000 1.0000 PVD 0.7110 0.6927 1.0000 Other 1.0000 1.0000 0.1498 >3 factors 0.0931 0.4770 0.5142 Preprocedural U/S velocity 0.9746 0.6557 0.3544 Postprocedural U/S velocity 0.7409 0.8019 0.8061 Note: Boldface indicates statistical significance. (P <.10).
Procedural Predictors All Neurocomplications Permanent Neurocomplications Neurologic Mortality Initial vs. later experience 0.6485 0.6481 1.0000 Primary Interventionalist: TM 0.2677 0.4355 0.5277 JP 0.4401 1.0000 1.0000 JB 0.3846 0.2821 0.0513 PR 0.6857 0.6486 1.0000 Type of stent (velocity vs. other) 0.8394 0.7983 0.4872 Use of abciximab 0.2591 0.6985 1.0000 Note: Boldface indicates statistical significance. (P <.10).
Angiographic Predictors All Neurocomplications Permanent Neurocomplications Neurologic Mortality Basilar lesion 0.2651 0.1552 1.0000 Maximum stenosis: Percentage 0.3186 0.4652 0.7075 L/S ratio 0.5460 0.2441 0.0518 Residual 0.1386 0.2459 0.1144 Concentric 0.4551 1.0000 1.0000 Mori A 0.7267 0.4110 0.1477 Mori B 1.0000 1.0000 0.0530 Mori C 0.6285 0.1167 1.0000 Tandem or bilateral vertebral artery lesions: Presence 0.9658 0.7139 0.5294 Both treated 1.0000 1.0000 1.0000 >50% 0.8002 1.0000 0.5134 PICA distal to lesion 0.3201 1.0000 1.0000 AICA distal to lesion 0.6372 0.6305 0.4444 Presence of collaterals 0.9808 0.4328 1.0000 Ulceration 1.0000 0.6493 0.3176 Note: Boldface indicates statistical significance. (P <.10).
In this issue
Stent-Assisted Angioplasty of Intracranial Vertebrobasilar Atherosclerosis: Midterm Analysis of Clinical and Radiologic Predictors of Neurological Morbidity and Mortality
Jump to section
Related Articles
Cited By...
- Stenting for intracranial stenosis: potential future for the prevention of disabling or fatal stroke
- Symptom Differences and Pretreatment Asymptomatic Interval Affect Outcomes of Stenting for Intracranial Atherosclerotic Disease
- Standard of practice: endovascular treatment of intracranial atherosclerosis
- Wingspan Stents for the Treatment of Symptomatic Atherosclerotic Stenosis in Small Intracranial Vessels: Safety and Efficacy Evaluation
- Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
- Reporting standards for angioplasty and stent-assisted angioplasty for intracranial atherosclerosis
- A Systematic Review on Outcome After Stenting for Intracranial Atherosclerosis
- Reporting Standards for Angioplasty and Stent-Assisted Angioplasty for Intracranial Atherosclerosis
- Subacute Stent Thrombosis in Intracranial Stenting
- Endovascular Therapy of Symptomatic Intracranial Stenosis in Patients With Impaired Regional Cerebral Blood Flow or Failure of Medical Therapy
- Emerging Endovascular Therapies for Symptomatic Intracranial Atherosclerotic Disease
- Long-term outcome of elective stenting for symptomatic intracranial vertebrobasilar stenosis
- US Multicenter Experience With the Wingspan Stent System for the Treatment of Intracranial Atheromatous Disease: Periprocedural Results
- Perforator stroke after elective stenting of symptomatic intracranial stenosis